© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Minerva Neurosciences, Inc. (NERV) shows an Average True Range (ATR) of 0.5 and an Enterprise Value of 58.63M. Its average trading volume over the past 3 months is 216.78K, indicating liquidity. These fundamental metrics provide insight into NERV's underlying financial health and market activity.
| ATR | 0.5 |
| Enterprise Value | 58.63M |
| Avg Vol (3 Months) | 216.78K |
| Avg Vol (10 Days) | 232.48K |
Minerva Neurosciences, Inc. (NERV) technical indicators as of April 16, 2026: the SMA 20 is 10.28%, SMA 50 at 30.76%, and SMA 200 at 102.56%. The RSI 14 value is 67.11, suggesting its current momentum. These technical analysis signals help assess NERV's price trends and potential future movements.
| SMA 20 | 10.28% |
| SMA 50 | 30.76% |
| SMA 200 | 102.56% |
| RSI 14 | 67.11 |
Minerva Neurosciences, Inc. (NERV) stock performance overview as of April 16, 2026: The 52-week high is $12.46 (currently -50% below), and the 52-week low is $1.3 (currently 441.74% above). Over the past year, NERV's performance is 104.22%, compared to the S&P 500's 25.19% change.
| 52-Week High | 12.46 |
| 52-Week High Chg | -50.00% |
| 52-Week Low | 1.3 |
| 52-Week Low Chg | +441.74% |
| S&P 500 52-Week Chg | 25.19% |
According to market data, Minerva Neurosciences, Inc. (NERV) stock's recent performance metrics show that over the last month, NERV is 15%, with a Year-to-Date (YTD) performance of 8.71%. Over the past year, the stock has seen a 104.22% change. These figures summarize NERV's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 6.09 | 8.8 | 8.8 | 12.46 | 12.46 | 8.8 |
| Low | 5.13 | 5.02 | 3.75 | 2.12 | 1.3 | 3.75 |
| Performance | +1.16% | +15.00% | +75.50% | +125.15% | +104.22% | +8.71% |
According to current financial data, NERV stock's P/E (TTM) ratio is -0.22, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for NERV, including P/S (N/A), P/B (-0.47), and P/FCF (-2.76), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | NERV | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -0.22 | -1.22 | -5.12 | 32.59 |
| P/S (TTM) | N/A | 3.69 | 464.32 | 5.98 |
| P/B (TTM) | -0.47 | 0.31 | 0.29 | 4.95 |
| P/FCF (TTM) | -2.76 | 39.26 | -554.58 | 34.42 |